Table 2.
Receptor binding affinity of selected quinoxaline-2,3-diones at recombinant homomeric iGluRs, determined in radioligand binding assays (all values in μM).
cmpd | Ki [μM] | ||||
---|---|---|---|---|---|
Recombinant Homomeric iGluRs | |||||
GluK1 | GluK2 | GluK3 | GluK5 | GluA2 | |
CNQX (1) | 1.3 ± 0.3 a | 1.1 ± 0.1 b
1.5 ± 0.01 a |
0.64 ± 0.05 a | 8.4 ± 0.9 c,d | 0.33 ± 0.03 a |
DNQX (2) | 0.65 ± 0.03 a | 2.1 ± 0.3 a | 0.36 ± 0.03 a | 7.1 ± 0.9 a | 0.25 ± 0.01 a |
NBQX (3) | 1.4 ± 0.4 e
12 ± 4 f 2.6 ± 0.1 d |
2.3 e
13 ± 2 f 5.4 ± 1.2 d |
3.2 e
24 ± 7 f 18 ± 8 b 3.4 ± 0.6 d |
19 ± 8 e
>100 f >100 c 152 ± 23 d |
0.26 ± 0.04 f 0.077 ± 0.010 d |
LU97175 (7) | 0.088 ± 0.033 e
0.70 ± 0.12 d |
0.31 ± 0.19 e
0.49 ± 0.06 d |
0.022 ± 0.003 e
0.19 ± 0.029 d |
6.9 ± 0.03 e
24 ± 4 d |
1.52 ± 0.25 d |
8 g | 0.0038 | 4.1 | 0.68 | 20 | nd |
9 g | 0.012 | 1.4 | 1.4 | 25 | nd |
10 g | 0.43 | 23 | nd | >30 | nd |
11 d | 1.1 ± 0.1 | 2.0 ± 0.1 | 0.53 ± 0.15 | 43 ± 11 | 4.9 ± 0.6 |
12 d | 0.80 ± 0.11 | 0.81 ± 0.08 | 0.28 ± 0.03 | 31 ± 4 | 6.2 ± 1.4 |
13 d | 1.1 ± 0.1 | 0.91 ± 0.17 | 0.14 ± 0.02 | 26 ± 2 | 4.1 ± 0.6 |
14 d | 0.80 ± 0.18 | 0.84 ± 0.19 | 0.33 ± 0.01 | 45 ± 4 | 6.0 ± 0.1 |
15 h | 0.17 ± 0.01 | 0.52 ± 0.14 | 0.08 ± 0.01 | 5.2 ± 0.30 | 5.7 ± 0.3 |
16 d | >100 | ≈100 | 2.9 ± 0.3 | >100 | 24 ± 6 |
17 i | ≈100 | >100 | 0.25 ± 0.01 | >100 | >100 |
18 i | 0.15 ± 0.05 | 0.091 ± 0.01 | 0.13 ± 0.03 | 3.8 ± 0.1 | 0.23 ± 0.02 |
19 a | 16 ± 1 | 9.5 ± 1.2 | 59 ± 3 | nd | 21 ± 2 |
20 j | 1.2 ± 0.7 | 33 ± 3 | 37 ± 4 | nd | >100 |
a ref. [98], radioligands: GluA2, [3H]AMPA; GluK1-3, [3H](2S,4R)-4-methyl-Glu ([3H]SYM2081) or [3H]KA; b ref. [99], radioligand: [3H]KA; c ref. [13], radioligand: [3H]KA; d ref. [92], radioligands: GluA2, [3H]AMPA; GluK1, [3H]KA or (S)-2-amino-3-(6-[3H]-2,4-dioxo-3,4-dihydrothieno [3,2-d]pyrimidin-1(2H)-yl)propanoic acid ([3H]-(S)-NF608); GluK2,3,5, [3H]KA; e ref. [72], radioligand: [3H]KA; f ref. [100], radioligands: GluA2, [3H]AMPA; GluK1-3,5 and GluK5, [3H]KA; g ref. [94], radioligand: [3H]KA; h ref. [95], radioligands: GluA2, [3H]AMPA; GluK1, [3H]-(S)-NF608; GluK2,3,5, [isopropenyl-3H]-kainic acid; i ref. [97], radioligands: GluA2, [3H]AMPA; GluK1, [3H]-(S)-NF608; GluK2,3,5, [isopropenyl-3H]-kainic acid; j ref. [101], radioligands: GluA2, [3H]AMPA; GluK1, [3H]-(S)-NF608; GluK2,3, [3H]KA; nd—not determined.